366 related articles for article (PubMed ID: 22183856)
1. Retinoic acid receptor-related orphan receptor α-induced activation of adenosine monophosphate-activated protein kinase results in attenuation of hepatic steatosis.
Kim EJ; Yoon YS; Hong S; Son HY; Na TY; Lee MH; Kang HJ; Park J; Cho WJ; Kim SG; Koo SH; Park HG; Lee MO
Hepatology; 2012 May; 55(5):1379-88. PubMed ID: 22183856
[TBL] [Abstract][Full Text] [Related]
2. Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones.
Hwahng SH; Ki SH; Bae EJ; Kim HE; Kim SG
Hepatology; 2009 Jun; 49(6):1913-25. PubMed ID: 19378344
[TBL] [Abstract][Full Text] [Related]
3. Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activation.
Han CY; Ki SH; Kim YW; Noh K; Lee DY; Kang B; Ryu JH; Jeon R; Kim EH; Hwang SJ; Kim SG
Antioxid Redox Signal; 2011 Jan; 14(2):187-202. PubMed ID: 20560786
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of liver X receptor-α-dependent hepatic steatosis by isoliquiritigenin, a licorice antioxidant flavonoid, as mediated by JNK1 inhibition.
Kim YM; Kim TH; Kim YW; Yang YM; Ryu DH; Hwang SJ; Lee JR; Kim SC; Kim SG
Free Radic Biol Med; 2010 Dec; 49(11):1722-34. PubMed ID: 20840863
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction.
Jin SH; Yang JH; Shin BY; Seo K; Shin SM; Cho IJ; Ki SH
Toxicol Appl Pharmacol; 2013 Aug; 271(1):95-105. PubMed ID: 23651738
[TBL] [Abstract][Full Text] [Related]
6. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
[TBL] [Abstract][Full Text] [Related]
7. Nectandrin B, a lignan isolated from nutmeg, inhibits liver X receptor-α-induced hepatic lipogenesis through AMP-activated protein kinase activation.
Choi du G; Kim EK; Yang JW; Song JS; Kim YM
Pharmazie; 2015 Nov; 70(11):733-9. PubMed ID: 26790190
[TBL] [Abstract][Full Text] [Related]
8. LXR-α antagonist meso-dihydroguaiaretic acid attenuates high-fat diet-induced nonalcoholic fatty liver.
Sim WC; Park S; Lee KY; Je YT; Yin HQ; Choi YJ; Sung SH; Park SJ; Park HJ; Shin KJ; Lee BH
Biochem Pharmacol; 2014 Aug; 90(4):414-24. PubMed ID: 24955981
[TBL] [Abstract][Full Text] [Related]
9. An active metabolite of oltipraz (M2) increases mitochondrial fuel oxidation and inhibits lipogenesis in the liver by dually activating AMPK.
Kim TH; Eom JS; Lee CG; Yang YM; Lee YS; Kim SG
Br J Pharmacol; 2013 Apr; 168(7):1647-61. PubMed ID: 23145499
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
Lee JM; Gang GT; Kim DK; Kim YD; Koo SH; Lee CH; Choi HS
J Biol Chem; 2014 Jan; 289(2):1079-91. PubMed ID: 24265317
[TBL] [Abstract][Full Text] [Related]
11. Combination of honokiol and magnolol inhibits hepatic steatosis through AMPK-SREBP-1 c pathway.
Lee JH; Jung JY; Jang EJ; Jegal KH; Moon SY; Ku SK; Kang SH; Cho IJ; Park SJ; Lee JR; Zhao RJ; Kim SC; Kim YW
Exp Biol Med (Maywood); 2015 Apr; 240(4):508-18. PubMed ID: 25125496
[TBL] [Abstract][Full Text] [Related]
12. Rimonabant, a cannabinoid receptor type 1 inverse agonist, inhibits hepatocyte lipogenesis by activating liver kinase B1 and AMP-activated protein kinase axis downstream of Gα i/o inhibition.
Wu HM; Yang YM; Kim SG
Mol Pharmacol; 2011 Nov; 80(5):859-69. PubMed ID: 21803969
[TBL] [Abstract][Full Text] [Related]
13. The Hexane Fraction of cyperus rotundus Prevents Non-Alcoholic Fatty Liver Disease Through the Inhibition of Liver X Receptor α-Mediated Activation of Sterol Regulatory Element Binding Protein-1c.
Oh GS; Yoon J; Lee GG; Kwak JH; Kim SW
Am J Chin Med; 2015; 43(3):477-94. PubMed ID: 25967664
[TBL] [Abstract][Full Text] [Related]
14. Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3).
Wada T; Kang HS; Angers M; Gong H; Bhatia S; Khadem S; Ren S; Ellis E; Strom SC; Jetten AM; Xie W
Mol Pharmacol; 2008 Mar; 73(3):891-9. PubMed ID: 18055760
[TBL] [Abstract][Full Text] [Related]
15. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
16. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis.
Kim YW; Kim YM; Yang YM; Kim TH; Hwang SJ; Lee JR; Kim SC; Kim SG
Free Radic Biol Med; 2010 Feb; 48(4):567-78. PubMed ID: 20005944
[TBL] [Abstract][Full Text] [Related]
18. Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase.
Lee JH; Baek SY; Jang EJ; Ku SK; Kim KM; Ki SH; Kim CE; Park KI; Kim SC; Kim YW
Chem Biol Interact; 2018 Jun; 289():68-74. PubMed ID: 29702089
[TBL] [Abstract][Full Text] [Related]
19. Involvement of adenosine monophosphate-activated protein kinase in the influence of timed high-fat evening diet on the hepatic clock and lipogenic gene expression in mice.
Huang Y; Zhu Z; Xie M; Xue J
Nutr Res; 2015 Sep; 35(9):792-9. PubMed ID: 26239949
[TBL] [Abstract][Full Text] [Related]
20. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma.
Na TY; Shin YK; Roh KJ; Kang SA; Hong I; Oh SJ; Seong JK; Park CK; Choi YL; Lee MO
Hepatology; 2009 Apr; 49(4):1122-31. PubMed ID: 19105208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]